Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
10
83%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
Suspended1
unknown1
Withdrawn1
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (8.3%)
Phase 31 (8.3%)
N/A10 (83.3%)

Trials by Status

suspended18%
unknown18%
withdrawn18%
enrolling_by_invitation18%
not_yet_recruiting18%
completed758%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12